Skip to main content
Top

Breast Cancer Research and Treatment

Issue 1/2005

Content (11 Articles)

Report

Quantitation of HDAC1 mRNA Expression in Invasive Carcinoma of the Breast*

Zhenhuan Zhang, Hiroko Yamashita, Tatsuya Toyama, Hiroshi Sugiura, Yoshiaki Ando, Keiko Mita, Maho Hamaguchi, Yasuo Hara, Shunzo Kobayashi, Hirotaka Iwase

Report

Assessment of Breast Cancer Tumor Size Depends on Method, Histopathology and Tumor Size Itself*

K. Heusinger, C. Löhberg, M. P. Lux, T. Papadopoulos, K. Imhoff, R. Schulz-Wendtland, M. W. Beckmann, P. A. Fasching

Report

Synuclein Gamma Inhibits the Mitotic Checkpoint Function and Promotes Chromosomal Instability of Breast Cancer Cells

Satoru Inaba, Cong Li, Y. Eric Shi, Dan-Qing Song, Jian-Dong Jiang, Jingwen Liu

Report

Nordihydroguaiaretic Acid (NDGA) Inhibits the IGF-1 and c-erbB2/HER2/neu Receptors and Suppresses Growth in Breast Cancer Cells

Jack F. Youngren, Karissa Gable, Cristina Penaranda, Betty A. Maddux, Marianna Zavodovskaya, Margaret Lobo, Michael Campbell, John Kerner, Ira D. Goldfine

Report

Celecoxib Inhibits Urokinase-Type Plasminogen Activator (uPA) Production in MDA-MB-231 Breast Cancer Cells

Heather N. Andrews, Golerah Habibi, Jill E. Kucab, Sandra E. Dunn

Report

Electrophysiological Correlates of Information Processing in Breast-Cancer Patients Treated With Adjuvant Chemotherapy

Baudewijntje P. C. Kreukels, Sanne B. Schagen, K. Richard Ridderinkhof, Willem Boogerd, Hans L. Hamburger, Frits S. A. M. van Dam

Report

Angiogenic Molecule Expression is Downregulated in Effusions from Breast Cancer Patients

Sophya Konstantinovsky, Søren Nielsen, Mogens Vyberg, Gunnar Kvalheim, Jahn M. Nesland, Reuven Reich, Ben Davidson

Letter to the Editor

Topical Imiquimod to Treat Recurrent Breast Cancer

Ulrich R. Hengge, Stephan Roth, Andrea Tannapfel

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine